Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CASPASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | CASPASE |
graph TD
CASPASE["CASPASE"]
style CASPASE fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
CASPASE -->|"activates"| PANoptosis["PANoptosis"]
CASPASE -->|"cleaves"| GSDME([GSDME])
CASPASE -->|"activates"| neurodegeneration["neurodegeneration"]
CASPASE -->|"activates"| IL1B([IL1B])
CASPASE -->|"regulates"| Fibrosis["Fibrosis"]
CASPASE -->|"interacts"| Cancer["Cancer"]
CASPASE -->|"interacts"| Als["Als"]
CASPASE -.->|"inhibits"| Aging["Aging"]
RIPK1([RIPK1]) -->|"interacts"| CASPASE
PPARG([PPARG]) -->|"interacts"| CASPASE
WNT([WNT]) -->|"regulates"| CASPASE
TFEB([TFEB]) -->|"interacts"| CASPASE
CFTR([CFTR]) -->|"regulates"| CASPASE
RICTOR([RICTOR]) -->|"interacts"| CASPASE
ROS([ROS]) -->|"regulates"| CASPASE
GRB2([GRB2]) -->|"interacts"| CASPASE
HSP70([HSP70]) -->|"interacts"| CASPASE
STAT3([STAT3]) -->|"interacts"| CASPASE| Target | Relation | Type | Str |
|---|---|---|---|
| PANoptosis | activates | process | 0.92 |
| neurodegeneration | activates | process | 0.70 |
| Parkinson | inhibits | disease | 0.60 |
| Pyroptosis | activates | disease | 0.60 |
| Neurodegeneration | inhibits | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Retinopathy | associated_with | disease | 0.60 |
| Cardiomyopathy | associated_with | disease | 0.60 |
| Huntington | expressed_in | disease | 0.60 |
| Alzheimer | expressed_in | disease | 0.60 |
| Stroke | inhibits | disease | 0.60 |
| Hypertension | inhibits | disease | 0.60 |
| Depression | interacts_with | disease | 0.60 |
| Lymphoma | phosphorylates | disease | 0.60 |
| Multiple Sclerosis | activates | disease | 0.60 |
| Traumatic Brain Injury | inhibits | disease | 0.60 |
| Necroptosis | protects_against | disease | 0.60 |
| Parkinson | protects_against | disease | 0.60 |
| Als | protects_against | disease | 0.60 |
| Schizophrenia | expressed_in | disease | 0.60 |
| Anxiety | expressed_in | disease | 0.60 |
| Depression | expressed_in | disease | 0.60 |
| Pyroptosis | causes | disease | 0.60 |
| Stroke | activates | disease | 0.60 |
| Neurodegeneration | activates | disease | 0.60 |
| Als | associated_with | disease | 0.60 |
| Neuroinflammation | associated_with | disease | 0.60 |
| Neurodegeneration | associated_with | disease | 0.60 |
| Als | therapeutic_target | disease | 0.60 |
| Neuroinflammation | therapeutic_target | disease | 0.60 |
| Cancer | expressed_in | disease | 0.60 |
| Dementia | causes | disease | 0.60 |
| Neurodegeneration | causes | disease | 0.60 |
| Diabetes | inhibits | disease | 0.60 |
| Cardiomyopathy | inhibits | disease | 0.60 |
| Alzheimer | regulates | disease | 0.60 |
| Lymphoma | expressed_in | disease | 0.60 |
| Als | causes | disease | 0.60 |
| Neuroinflammation | causes | disease | 0.60 |
| Alzheimer | associated_with | disease | 0.60 |
| Parkinson | activates | disease | 0.60 |
| Dementia | activates | disease | 0.60 |
| Frontotemporal Dementia | activates | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Alzheimer | causes | disease | 0.60 |
| Dementia | therapeutic_target | disease | 0.60 |
| Alzheimer | therapeutic_target | disease | 0.60 |
| Stroke | therapeutic_target | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| UBIQUITIN | inhibits | gene | 0.60 |
| CX43 | inhibits | gene | 0.60 |
| ASTROCYTES | inhibits | gene | 0.60 |
| VEGF | associated_with | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| NRF2 | associated_with | gene | 0.60 |
| FIS1 | associated_with | gene | 0.60 |
| HO-1 | associated_with | gene | 0.60 |
| TLR | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| CREB | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| TAAR1 | associated_with | gene | 0.60 |
| HUNTINGTON | expressed_in | gene | 0.60 |
| GAIN | causes | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| NRF2 | degrades | gene | 0.60 |
| STROKE | inhibits | gene | 0.60 |
| KEAP1 | degrades | gene | 0.60 |
| HO-1 | degrades | gene | 0.60 |
| NLRP3 | degrades | gene | 0.60 |
| NQO1 | expressed_in | gene | 0.60 |
| IL-1 | expressed_in | gene | 0.60 |
| IL-6 | expressed_in | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| ASC | inhibits | gene | 0.60 |
| STROKE | therapeutic_target | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| IL-4 | therapeutic_target | gene | 0.60 |
| ALS | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| IL-1 | therapeutic_target | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| GPX4 | activates | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| XCT | activates | gene | 0.60 |
| COX2 | activates | gene | 0.60 |
| NCOA4 | activates | gene | 0.60 |
| HO-1 | activates | gene | 0.60 |
| AIM2 | regulates | gene | 0.60 |
| MLKL | regulates | gene | 0.60 |
| RIPK3 | activates | gene | 0.60 |
| ZBP1 | regulates | gene | 0.60 |
| GSDMD | regulates | gene | 0.60 |
| TBK1 | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| GASDERMIN | regulates | gene | 0.60 |
| IRF3 | activates | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Caspase-2/3-mediated D421 truncation generates disease-speci | 0.455 | neurodegeneration | Which specific post-translational modifi |
| NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhib | 0.105 | neurodegeneration | Neuroinflammation Biomarker Panel for Ea |
| Caspase-3 Cleavage of Tau Creates PS-Targeting Specificity | 0.000 | - | Does tau aggregation specifically cause |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CASPASE in their description or question text
No additional research found